CA2612044A1 - Capsule contenant un emetique - Google Patents

Capsule contenant un emetique Download PDF

Info

Publication number
CA2612044A1
CA2612044A1 CA002612044A CA2612044A CA2612044A1 CA 2612044 A1 CA2612044 A1 CA 2612044A1 CA 002612044 A CA002612044 A CA 002612044A CA 2612044 A CA2612044 A CA 2612044A CA 2612044 A1 CA2612044 A1 CA 2612044A1
Authority
CA
Canada
Prior art keywords
emetic
drug
capsule
embedded
encapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002612044A
Other languages
English (en)
Other versions
CA2612044C (fr
Inventor
Paul Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2612044A1 publication Critical patent/CA2612044A1/fr
Application granted granted Critical
Publication of CA2612044C publication Critical patent/CA2612044C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2612044A 2005-06-13 2006-06-13 Capsule contenant un emetique Expired - Fee Related CA2612044C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69002305P 2005-06-13 2005-06-13
US60/690,023 2005-06-13
PCT/US2006/022939 WO2006138278A1 (fr) 2005-06-13 2006-06-13 Capsule contenant un émétique

Publications (2)

Publication Number Publication Date
CA2612044A1 true CA2612044A1 (fr) 2006-12-28
CA2612044C CA2612044C (fr) 2016-02-02

Family

ID=37570767

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2612044A Expired - Fee Related CA2612044C (fr) 2005-06-13 2006-06-13 Capsule contenant un emetique

Country Status (4)

Country Link
EP (1) EP1893183A4 (fr)
JP (1) JP2008543851A (fr)
CA (1) CA2612044C (fr)
WO (1) WO2006138278A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2910865C (fr) 2014-07-15 2016-11-29 Isa Odidi Compositions et methodes destines a reduire les surdoses
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
EP3209282A4 (fr) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Forme galénique anti-abus de remplissage de liquide à libération prolongée

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1428361A (en) * 1972-02-15 1976-03-17 Grant A Safeguarded medicinal compositions
IE46306B1 (en) * 1977-02-11 1983-05-04 Ici Ltd Safeguarded toxic chemical compositions containing an emetic
US4175119A (en) * 1978-01-11 1979-11-20 Porter Garry L Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
US4529583A (en) * 1983-03-07 1985-07-16 Clear Lake Development Group Composition and method of immobilizing emetics and method of treating human beings with emetics
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
AU2002339378A1 (en) * 2001-05-22 2002-12-03 Euro-Celtique Compartmentalized dosage form
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US7524515B2 (en) * 2003-01-10 2009-04-28 Mutual Pharmaceuticals, Inc. Pharmaceutical safety dosage forms
CA2536816A1 (fr) * 2003-08-12 2005-03-03 Endo Pharmaceuticals, Inc. Procede permettant d'empecher l'abus d'opioides par combinaison avec une formulation non liberable d'emetique

Also Published As

Publication number Publication date
EP1893183A4 (fr) 2010-08-18
WO2006138278A1 (fr) 2006-12-28
EP1893183A1 (fr) 2008-03-05
JP2008543851A (ja) 2008-12-04
CA2612044C (fr) 2016-02-02

Similar Documents

Publication Publication Date Title
US9060950B2 (en) Emetic embedded capsule
US10653776B2 (en) Compositions and methods for reducing overdose
EP3273948B1 (fr) Capsules molles remplies de liquide
AU2005305232B2 (en) Non-gelatin soft capsule system
CA2612044C (fr) Capsule contenant un emetique
JP2006514067A (ja) 製薬学的安全投薬形態物
HUT54038A (en) Process for producing compositions with hydrogel-operated controlled release of active ingredient
US10166207B2 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
US20090123386A1 (en) Abuse Resistant Capsules
CA2888278A1 (fr) Formulations de medicament pour administration par voie orale
Ubhe et al. A brief overview on tablet and it’s types
AU2006275718A1 (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
EP1177788B1 (fr) Composition pharmaceutique à base de fluoxétine sous forme de comprimés enrobés dispersibles et son procédé de fabrication
US10357461B2 (en) Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
Vadivelu et al. The clinical applications of extended-release abuse-deterrent opioids
US20200138767A1 (en) Hydroxycitric acid compounds and capsule liquid delivery
AU2003224419A1 (en) Orally administrable pharmaceutical formulation
US20080274188A1 (en) Oral Vehicle For Systemic Pharmaceuticals
US20190343770A1 (en) Hard Capsule Shell Compositions for the Oral Contraceptive Formulations
US20190388354A1 (en) Improved compositions and methods for reducing overdose
US20030158263A1 (en) Orally administrable pharmaceutical formulation
Mohammad et al. Abuse Deterrent Dosage Forms: Approaches, Advantages and Limitations
US20180256671A1 (en) Hard Capsule Shell Compositions for the Treatment of Irritable Bowel Syndrome
US20110092532A1 (en) Apomorphine pharmaceutical dosage security system
OFFERS Solid Dosage Forms: Tablets

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190613